0001209191-23-040328.txt : 20230630
0001209191-23-040328.hdr.sgml : 20230630
20230630163012
ACCESSION NUMBER: 0001209191-23-040328
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230622
FILED AS OF DATE: 20230630
DATE AS OF CHANGE: 20230630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lawton Alison Frances
CENTRAL INDEX KEY: 0001542650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37722
FILM NUMBER: 231062163
MAIL ADDRESS:
STREET 1: 39 ROBINSON ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02420
FORMER NAME:
FORMER CONFORMED NAME: LAWTON ALISON FRANCIS
DATE OF NAME CHANGE: 20120216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc.
CENTRAL INDEX KEY: 0001636282
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464312787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: (512) 942-2935
MAIL ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-22
0
0001636282
Aeglea BioTherapeutics, Inc.
AGLE
0001542650
Lawton Alison Frances
C/O AEGLEA BIOTHERAPEUTICS, INC.
805 LAS CIMAS PARKWAY, SUITE 100
AUSTIN
TX
78746
1
0
0
0
0
Stock Option (right to buy)
0.30
2023-06-22
5
A
0
E
1950000
0.00
A
2033-06-22
Common Stock
1950000
1950000
D
This option award is contingent upon receiving stockholder approval of the amendment and/or restatement of the 2016 Equity Incentive Plan to increase the number of shares available for issuance thereunder.
The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 22, 2023, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.
/s/ Jonathan Alspaugh, by power of attorney
2023-06-30